UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 94

Sortiert nach

Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma

Journal of translational medicine, 2012-03, Vol.10 (1), p.55-55, Article 55

2012

Link zum Volltext

Verfügbarkeit prüfen

Long-Term Efficacy and Safety of Enzalutamide Monotherapy in Elderly Patients with Metastatic Castration-Resistant Prostate Cancer: A Case Report

Case reports in oncology, 2024-01, Vol.17 (1), p.537-542

2024

Link zum Volltext

Verfügbarkeit prüfen

Real-World Evidence in Glioblastoma: Stupp's Regimen After a Decade

Frontiers in oncology, 2020-07, Vol.10, p.840-840

2020

Link zum Volltext

Verfügbarkeit prüfen

11C-methionine in the diagnostics and management of glioblastoma patients with rapid early progression: nonrandomized, open label, prospective clinical trial (GlioMET)

BMC cancer, 2024-06, Vol.24 (1), p.1-16, Article 736

2024

Link zum Volltext

Verfügbarkeit prüfen

Expression of miRNA-106b in conventional renal cell carcinoma is a potential marker for prediction of early metastasis after nephrectomy

Journal of experimental & clinical cancer research, 2010-07, Vol.29 (1), p.90-90, Article 90

2010

Link zum Volltext

Verfügbarkeit prüfen

MiR-429 is linked to metastasis and poor prognosis in renal cell carcinoma by affecting epithelial-mesenchymal transition

Tumor biology, 2016-11, Vol.37 (11), p.14653-14658

2016

Link zum Volltext

Verfügbarkeit prüfen

Neoadjuvant Chemotherapy of Triple-Negative Breast Cancer: Evaluation of Early Clinical Response, Pathological Complete Response Rates, and Addition of Platinum Salts Benefit Based on Real-World Evidence

Cancers, 2021-03, Vol.13 (7), p.1586

2021

Link zum Volltext

Verfügbarkeit prüfen

The association of miR-126-3p, miR-126-5p and miR-664-3p expression profiles with outcomes of patients with metastatic colorectal cancer treated with bevacizumab

Tumor biology, 2017-07, Vol.39 (7), p.1010428317709283-1010428317709283

2017

Link zum Volltext

Verfügbarkeit prüfen

Transgelin Contributes to a Poor Response of Metastatic Renal Cell Carcinoma to Sunitinib Treatment

Biomedicines, 2021-09, Vol.9 (9), p.1145

2021

Link zum Volltext

Verfügbarkeit prüfen

Patients with metastatic renal cell carcinoma treated with cabozantinib in the Czech Republic: analysis of four cancer centers

Biomedical papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia, 2022-03, Vol.166 (1), p.97-104

2022

Link zum Volltext

Verfügbarkeit prüfen

Cytoreductive Nephrectomy and Overall Survival of Patients with Metastatic Renal Cell Carcinoma Treated with Targeted Therapy—Data from the National Renis Registry

Cancers, 2020-10, Vol.12 (10), p.2911

2020

Link zum Volltext

Verfügbarkeit prüfen

Outcomes According to MSKCC Risk Score with Focus on the Intermediate-Risk Group in Metastatic Renal Cell Carcinoma Patients Treated with First-Line Sunitinib: A Retrospective Analysis of 2390 Patients

Cancers, 2020-03, Vol.12 (4), p.808

2020

Link zum Volltext

Verfügbarkeit prüfen

Utilization and efficacy of second-line targeted therapy in metastatic renal cell carcinoma: data from a national registry

BMC cancer, 2017-12, Vol.17 (1), p.880-880, Article 880

2017

Link zum Volltext

Verfügbarkeit prüfen

Planned Discontinuation of Tyrosine Kinase Inhibitor Therapy in Metastatic Renal Cell Carcinoma: Lessons for the Era of Immunotherapy

Targeted oncology, 2024-03, Vol.19 (2), p.175-180

2024

Link zum Volltext

Verfügbarkeit prüfen

Biomarker Dynamics and Long-Term Treatment Outcomes in Breast Cancer Patients with Residual Cancer Burden after Neoadjuvant Therapy

Diagnostics (Basel), 2022-07, Vol.12 (7), p.1740

2022

Link zum Volltext

Verfügbarkeit prüfen

Sequential Treatment with Bevacizumab and Aflibercept for Metastatic Colorectal Cancer in Real-World Clinical Practice

Targeted oncology, 2020-04, Vol.15 (2), p.193-201

2020

Link zum Volltext

Verfügbarkeit prüfen

Pre-Radiotherapy Progression after Surgery of Newly Diagnosed Glioblastoma: Corroboration of New Prognostic Variable

Diagnostics (Basel), 2020-09, Vol.10 (9), p.676

2020

Link zum Volltext

Verfügbarkeit prüfen

New treatment options for metastatic renal cell carcinoma

Onkologie (Olomouc), 2022-02, Vol.16 (1), p.20-24

2022

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of everolimus in second- and third-line therapy for metastatic renal cell carcinoma: A registry-based analysis

Urologic oncology, 2014-07, Vol.32 (5), p.569-575

2014

Link zum Volltext

Verfügbarkeit prüfen

Clinical and laboratory prognostic factors in patients with metastatic renal cell carcinoma treated with sunitinib and sorafenib after progression on cytokines

Urologic oncology, 2014-05, Vol.32 (4), p.488-495

2014

Link zum Volltext

Verfügbarkeit prüfen

HLA-G and HLA-E specific mRNAs connote opposite prognostic significance in renal cell carcinoma

Diagnostic pathology, 2012-05, Vol.7 (1), p.58-58, Article 58

2012

Link zum Volltext

Verfügbarkeit prüfen

Open-Label, Single-Arm Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Clear Cell Renal Cell Carcinoma

Journal of clinical oncology, 2021-03, Vol.39 (9), p.1020-1028

2021

Link zum Volltext

Verfügbarkeit prüfen

The use of cisplatin in patients after kidney transplantation with chronic renal insufficiency: Is the benefit higher than potential risks in therapy of non-seminomatous germ cell tumors?

Medicine (Baltimore), 2021-06, Vol.100 (24), p.e26381

2021

Link zum Volltext

Verfügbarkeit prüfen

A large‐scale assay library for targeted protein quantification in renal cell carcinoma tissues

Proteomics (Weinheim), 2022-04, Vol.22 (7), p.e2100228-n/a

2022

Link zum Volltext

Verfügbarkeit prüfen

Advances in the systemic treatment of brain metastases in malignant melanoma

Onkologie (Olomouc), 2021-09, Vol.15 (4), p.164-168

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 94

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(93)
Mit Volltextzugriff
(92)

Publikationsform

Artikel
(93)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(63)
Life Sciences & Biomedicine
(62)
Oncology
(47)
Humans
(45)
Female
(35)
Male
(35)
Middle Aged
(34)
Aged
(31)
Adult
(28)
Renal Cell Carcinoma
(26)
Metastasis
(25)
Tumors
(21)
Aged, 80 And Over
(19)
Patients
(18)
Chemotherapy
(17)
Neoplasm Metastasis
(17)
Retrospective Studies
(17)
Carcinoma, Renal Cell - Drug Therapy
(16)
Biomarkers
(15)
Kidney Cancer
(15)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma

Long-Term Efficacy and Safety of Enzalutamide Monotherapy in Elderly Patients with Metastatic Castration-Resistant Prostate Cancer: A Case Report

Real-World Evidence in Glioblastoma: Stupp's Regimen After a Decade

11C-methionine in the diagnostics and management of glioblastoma patients with rapid early progression: nonrandomized, open label, prospective clinical trial (GlioMET)

Expression of miRNA-106b in conventional renal cell carcinoma is a potential marker for prediction of early metastasis after nephrectomy

MiR-429 is linked to metastasis and poor prognosis in renal cell carcinoma by affecting epithelial-mesenchymal transition

Neoadjuvant Chemotherapy of Triple-Negative Breast Cancer: Evaluation of Early Clinical Response, Pathological Complete Response Rates, and Addition of Platinum Salts Benefit Based on Real-World Evidence

The association of miR-126-3p, miR-126-5p and miR-664-3p expression profiles with outcomes of patients with metastatic colorectal cancer treated with bevacizumab

Transgelin Contributes to a Poor Response of Metastatic Renal Cell Carcinoma to Sunitinib Treatment

Patients with metastatic renal cell carcinoma treated with cabozantinib in the Czech Republic: analysis of four cancer centers

Cytoreductive Nephrectomy and Overall Survival of Patients with Metastatic Renal Cell Carcinoma Treated with Targeted Therapy—Data from the National Renis Registry

Outcomes According to MSKCC Risk Score with Focus on the Intermediate-Risk Group in Metastatic Renal Cell Carcinoma Patients Treated with First-Line Sunitinib: A Retrospective Analysis of 2390 Patients

Utilization and efficacy of second-line targeted therapy in metastatic renal cell carcinoma: data from a national registry

Planned Discontinuation of Tyrosine Kinase Inhibitor Therapy in Metastatic Renal Cell Carcinoma: Lessons for the Era of Immunotherapy

Biomarker Dynamics and Long-Term Treatment Outcomes in Breast Cancer Patients with Residual Cancer Burden after Neoadjuvant Therapy

Sequential Treatment with Bevacizumab and Aflibercept for Metastatic Colorectal Cancer in Real-World Clinical Practice

Pre-Radiotherapy Progression after Surgery of Newly Diagnosed Glioblastoma: Corroboration of New Prognostic Variable

New treatment options for metastatic renal cell carcinoma

Efficacy of everolimus in second- and third-line therapy for metastatic renal cell carcinoma: A registry-based analysis

Clinical and laboratory prognostic factors in patients with metastatic renal cell carcinoma treated with sunitinib and sorafenib after progression on cytokines

HLA-G and HLA-E specific mRNAs connote opposite prognostic significance in renal cell carcinoma

Open-Label, Single-Arm Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Clear Cell Renal Cell Carcinoma

The use of cisplatin in patients after kidney transplantation with chronic renal insufficiency: Is the benefit higher than potential risks in therapy of non-seminomatous germ cell tumors?

A large‐scale assay library for targeted protein quantification in renal cell carcinoma tissues

Advances in the systemic treatment of brain metastases in malignant melanoma

Suchergebnisse filtern